| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | phagophore | 4.55e-05 | 3 | 82 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | 3M complex | 1.51e-04 | 5 | 82 | 2 | GO:1990393 | |
| MousePheno | no spontaneous movement | 2.22e-05 | 123 | 65 | 6 | MP:0001404 | |
| Domain | ATG2 | 1.95e-05 | 2 | 83 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 1.95e-05 | 2 | 83 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 1.95e-05 | 2 | 83 | 2 | IPR026885 | |
| Domain | CTNNB1-bd_N | 1.16e-04 | 4 | 83 | 2 | IPR013558 | |
| Domain | CTNNB1_binding | 1.16e-04 | 4 | 83 | 2 | PF08347 | |
| Domain | TCF/LEF | 1.16e-04 | 4 | 83 | 2 | IPR024940 | |
| Domain | ATG_C | 1.93e-04 | 5 | 83 | 2 | PF09333 | |
| Domain | Autophagy-rel_C | 1.93e-04 | 5 | 83 | 2 | IPR015412 | |
| Domain | VPS13_N | 5.37e-04 | 8 | 83 | 2 | IPR026854 | |
| Domain | Chorein_N | 5.37e-04 | 8 | 83 | 2 | PF12624 | |
| Domain | p53-like_TF_DNA-bd | 1.69e-03 | 53 | 83 | 3 | IPR008967 | |
| Domain | AAA+_ATPase | 3.89e-03 | 144 | 83 | 4 | IPR003593 | |
| Domain | AAA | 3.89e-03 | 144 | 83 | 4 | SM00382 | |
| Domain | Catenin_binding_dom | 7.33e-03 | 29 | 83 | 2 | IPR027397 | |
| Domain | - | 7.33e-03 | 29 | 83 | 2 | 4.10.900.10 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 2.30e-04 | 6 | 56 | 2 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 2.30e-04 | 6 | 56 | 2 | M47736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 3.21e-04 | 7 | 56 | 2 | M47465 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 4.19e-04 | 37 | 56 | 3 | M29790 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 4.27e-04 | 8 | 56 | 2 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 4.27e-04 | 8 | 56 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 4.27e-04 | 8 | 56 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 4.27e-04 | 8 | 56 | 2 | M27821 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 6.83e-04 | 10 | 56 | 2 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 6.83e-04 | 10 | 56 | 2 | MM15156 | |
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 8.67e-07 | 30 | 85 | 4 | 26593974 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.12e-06 | 430 | 85 | 9 | 35044719 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 FOCAD HSPG2 NCOR2 MDN1 DNAJC14 SNX8 LRP4 TRMT11 ATG2A BCAM SPEN MYRF | 2.78e-06 | 1105 | 85 | 13 | 35748872 |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28800131 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22219374 | ||
| Pubmed | Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. | 5.90e-06 | 2 | 85 | 2 | 21599871 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23224985 | ||
| Pubmed | A conserved ATG2-GABARAP family interaction is critical for phagophore formation. | 1.77e-05 | 3 | 85 | 2 | 32009292 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29920211 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27052530 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 24268649 | ||
| Pubmed | GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb. | 1.77e-05 | 3 | 85 | 2 | 21795403 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15016912 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 34525377 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 14661054 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 32403323 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12446687 | ||
| Pubmed | Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. | 1.77e-05 | 3 | 85 | 2 | 21282610 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 38211648 | ||
| Pubmed | The transcription factor Maz is essential for normal eye development. | 1.82e-05 | 21 | 85 | 3 | 32571845 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.52e-05 | 351 | 85 | 7 | 38297188 | |
| Pubmed | 2.75e-05 | 24 | 85 | 3 | 33722704 | ||
| Pubmed | 2.82e-05 | 808 | 85 | 10 | 20412781 | ||
| Pubmed | 3.06e-05 | 650 | 85 | 9 | 38777146 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12244173 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15684397 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 33587034 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12556497 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 16129689 | ||
| Pubmed | TCF transcription factors: molecular switches in carcinogenesis. | 3.53e-05 | 4 | 85 | 2 | 10528152 | |
| Pubmed | Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. | 3.53e-05 | 4 | 85 | 2 | 16121196 | |
| Pubmed | Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor. | 3.53e-05 | 4 | 85 | 2 | 15062576 | |
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 3.53e-05 | 4 | 85 | 2 | 17065530 | |
| Pubmed | 3.95e-05 | 27 | 85 | 3 | 23824573 | ||
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 3.95e-05 | 27 | 85 | 3 | 23395962 | |
| Pubmed | HSPG2 NCOR2 ZNF609 TCF7L2 GSE1 ATXN1 RPN1 CUL7 GTPBP1 FIGN SPEN MNT MYB | 4.24e-05 | 1429 | 85 | 13 | 35140242 | |
| Pubmed | 5.27e-05 | 83 | 85 | 4 | 28794006 | ||
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 5.87e-05 | 5 | 85 | 2 | 21285352 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 20027603 | ||
| Pubmed | Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. | 5.87e-05 | 5 | 85 | 2 | 22710871 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 15778499 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 12840049 | ||
| Pubmed | Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway. | 5.87e-05 | 5 | 85 | 2 | 21475249 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 15525529 | ||
| Pubmed | Regulation of the murine Ddelta2 promoter by upstream stimulatory factor 1, Runx1, and c-Myb. | 5.87e-05 | 5 | 85 | 2 | 15778374 | |
| Pubmed | 6.89e-05 | 282 | 85 | 6 | 23667531 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 7.48e-05 | 908 | 85 | 10 | 19274049 | |
| Pubmed | NCOR2 ZNF609 TCF7L2 GSE1 INPP5D UNG MTREX GTPBP1 SPEN MNT MYB | 7.76e-05 | 1103 | 85 | 11 | 34189442 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.96e-05 | 736 | 85 | 9 | 29676528 | |
| Pubmed | 7.98e-05 | 34 | 85 | 3 | 23293290 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 8.24e-05 | 180 | 85 | 5 | 35198878 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 16714285 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 9488439 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 23152144 | ||
| Pubmed | Activation of mouse RAG-2 promoter by Myc-associated zinc finger protein. | 8.80e-05 | 6 | 85 | 2 | 15094381 | |
| Pubmed | The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. | 8.80e-05 | 6 | 85 | 2 | 25915022 | |
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 8.80e-05 | 6 | 85 | 2 | 20128911 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 12408825 | ||
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 8.80e-05 | 6 | 85 | 2 | 24748645 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 37091972 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 8.80e-05 | 6 | 85 | 2 | 19304756 | |
| Pubmed | 1.14e-04 | 446 | 85 | 7 | 24255178 | ||
| Pubmed | 1.18e-04 | 102 | 85 | 4 | 10231032 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 11867749 | ||
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 1.23e-04 | 7 | 85 | 2 | 32820720 | |
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 1.23e-04 | 7 | 85 | 2 | 18772112 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 19303461 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 16204248 | ||
| Pubmed | Wnt signaling mediates regional specification in the vertebrate face. | 1.64e-04 | 8 | 85 | 2 | 17699607 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 22038040 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 15280358 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | NCOR2 ZNF609 TCF7L2 GSE1 RPN1 DHCR7 BCAM MNT LETM1 RNF111 GNPAT | 1.66e-04 | 1203 | 85 | 11 | 29180619 |
| Pubmed | Transcriptome profile of subsynaptic myonuclei at the neuromuscular junction in embryogenesis. | 2.10e-04 | 9 | 85 | 2 | 37994470 | |
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 2.10e-04 | 9 | 85 | 2 | 17335794 | |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 20370913 | ||
| Pubmed | 2.41e-04 | 1049 | 85 | 10 | 27880917 | ||
| Pubmed | Regulation of GATA-3 expression during CD4 lineage differentiation. | 2.62e-04 | 10 | 85 | 2 | 21357543 | |
| Pubmed | Dual-specificity phosphatase 18 modulates the SUMOylation and aggregation of Ataxin-1. | 2.62e-04 | 10 | 85 | 2 | 29852174 | |
| Pubmed | FOCAD PLEKHH1 DMXL2 ERBB3 DNAJC14 TPP1 LRP4 ZNF76 HUNK AMOTL2 RNF111 | 2.93e-04 | 1285 | 85 | 11 | 35914814 | |
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 11792727 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 21452227 | ||
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 3.20e-04 | 11 | 85 | 2 | 11731265 | |
| Pubmed | Tcf7L2 is essential for neurogenesis in the developing mouse neocortex. | 3.20e-04 | 11 | 85 | 2 | 29751817 | |
| Pubmed | Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. | 3.20e-04 | 11 | 85 | 2 | 11331609 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 3.81e-04 | 719 | 85 | 8 | 35337019 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 32414917 | ||
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 3.83e-04 | 12 | 85 | 2 | 10631168 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 12490567 | ||
| Pubmed | Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion. | 3.83e-04 | 12 | 85 | 2 | 19700620 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 3.83e-04 | 12 | 85 | 2 | 11266540 | |
| Pubmed | 4.36e-04 | 60 | 85 | 3 | 19075228 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 12668638 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 15226261 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 33075808 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 33195246 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 32160556 | ||
| Pubmed | Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. | 5.27e-04 | 14 | 85 | 2 | 10090727 | |
| Pubmed | 5.39e-04 | 152 | 85 | 4 | 38360978 | ||
| Pubmed | NCOR2 ABHD15 MDN1 DNAJC14 RPN1 DHCR7 RNF213 ERMP1 GTPBP1 GNPAT | 5.61e-04 | 1168 | 85 | 10 | 19946888 | |
| Pubmed | 5.72e-04 | 418 | 85 | 6 | 34709266 | ||
| Interaction | TBXT interactions | 8.40e-06 | 116 | 83 | 6 | int:TBXT | |
| Interaction | TLE3 interactions | 2.42e-05 | 376 | 83 | 9 | int:TLE3 | |
| Interaction | PRDM1 interactions | 2.51e-05 | 84 | 83 | 5 | int:PRDM1 | |
| Interaction | PAX2 interactions | 2.66e-05 | 85 | 83 | 5 | int:PAX2 | |
| Interaction | FHL2 interactions | 3.63e-05 | 396 | 83 | 9 | int:FHL2 | |
| Interaction | FNDC8 interactions | 5.26e-05 | 18 | 83 | 3 | int:FNDC8 | |
| Cytoband | 15q21 | 1.84e-04 | 11 | 85 | 2 | 15q21 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 7.48e-07 | 161 | 82 | 7 | M11857 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN | 1.47e-06 | 178 | 82 | 7 | M6728 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOR2 DMXL2 TCF7L2 FAM193A MDN1 GSE1 ATXN1 DUSP4 MAPK6 MTREX SPEN MNT | 1.38e-05 | 856 | 82 | 12 | M4500 |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 2.15e-05 | 52 | 82 | 4 | MM442 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 3.74e-05 | 198 | 82 | 6 | M6128 | |
| Coexpression | GSE17580_TREG_VS_TEFF_DN | 3.96e-05 | 200 | 82 | 6 | M3671 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3 | 2.39e-05 | 416 | 79 | 9 | GSM791146_500 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-07 | 167 | 84 | 6 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-06 | 185 | 84 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 1.57e-06 | 189 | 84 | 6 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 2.12e-06 | 199 | 84 | 6 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 2.18e-06 | 200 | 84 | 6 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 2.18e-06 | 200 | 84 | 6 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.63e-06 | 115 | 84 | 5 | 15b2c11225802cc15c01165d84a755432f02d82f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 152 | 84 | 5 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 152 | 84 | 5 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-05 | 153 | 84 | 5 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-05 | 153 | 84 | 5 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TEM|URO / Disease, Lineage and Cell Type | 1.31e-05 | 160 | 84 | 5 | e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 1.86e-05 | 172 | 84 | 5 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.86e-05 | 172 | 84 | 5 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.92e-05 | 173 | 84 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 174 | 84 | 5 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 178 | 84 | 5 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 178 | 84 | 5 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-05 | 178 | 84 | 5 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-05 | 181 | 84 | 5 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 181 | 84 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-05 | 182 | 84 | 5 | 6c9a48037fa002bc528875538bdaaf15696d68b6 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.64e-05 | 185 | 84 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.71e-05 | 186 | 84 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 2.93e-05 | 189 | 84 | 5 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.16e-05 | 192 | 84 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|World / Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | 79fa0f482cd98642b1d38835cda98622f21e5bd0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-05 | 193 | 84 | 5 | 53b3f9a8967541ca817a250439a7928d36b45386 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.32e-05 | 194 | 84 | 5 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.48e-05 | 196 | 84 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 3.48e-05 | 196 | 84 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.65e-05 | 198 | 84 | 5 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.65e-05 | 198 | 84 | 5 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 200 | 84 | 5 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive|Influenza_Severe / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | 0382f8fc27d18003761725e714beb6b3f3150057 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 84 | 4 | 2880f25d10a7765e55a2aa20c7a6ef74cea19c4d | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 84 | 4 | ecd0e54dd829201290212ea2ff7c8e7eec19c0e9 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 84 | 4 | cffd7730bda90828efc0def452cabb44cf93ab48 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-04 | 134 | 84 | 4 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-04 | 137 | 84 | 4 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 139 | 84 | 4 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 145 | 84 | 4 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-04 | 148 | 84 | 4 | 44128692824ca419fface0af41099c17135933ce | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-04 | 148 | 84 | 4 | d60f93311cfa718d026a0dbf61771bbbcbb79146 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 2.16e-04 | 156 | 84 | 4 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.27e-04 | 158 | 84 | 4 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-04 | 159 | 84 | 4 | 048b6a97568242c8846034277680632e5de75840 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 160 | 84 | 4 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-04 | 161 | 84 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 162 | 84 | 4 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 164 | 84 | 4 | f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.68e-04 | 165 | 84 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 2.74e-04 | 166 | 84 | 4 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.80e-04 | 167 | 84 | 4 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-04 | 168 | 84 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.87e-04 | 168 | 84 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.87e-04 | 168 | 84 | 4 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | d18b823836ca6fba79a2d2f10cb9966fa2623af2 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | befb9b1618ea30fbf8983bcc493853da53b809c3 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.93e-04 | 169 | 84 | 4 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 3.00e-04 | 170 | 84 | 4 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 3.00e-04 | 170 | 84 | 4 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-04 | 171 | 84 | 4 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 3.07e-04 | 171 | 84 | 4 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-04 | 171 | 84 | 4 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.07e-04 | 171 | 84 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-04 | 171 | 84 | 4 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.14e-04 | 172 | 84 | 4 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.14e-04 | 172 | 84 | 4 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.14e-04 | 172 | 84 | 4 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 174 | 84 | 4 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 174 | 84 | 4 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 174 | 84 | 4 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-04 | 174 | 84 | 4 | 0227fea1678baa9168bd47c3b4aacb2592bb5867 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-04 | 174 | 84 | 4 | c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-04 | 174 | 84 | 4 | 84024c04b0ce9f7068677d2d99ede56882b7dbd2 | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.28e-04 | 174 | 84 | 4 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 175 | 84 | 4 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 175 | 84 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-04 | 175 | 84 | 4 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 175 | 84 | 4 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.35e-04 | 175 | 84 | 4 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 175 | 84 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-04 | 175 | 84 | 4 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-04 | 175 | 84 | 4 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.42e-04 | 176 | 84 | 4 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.96e-06 | 158 | 84 | 7 | 4136_UP | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; MCF7; HT_HG-U133A | 6.64e-06 | 190 | 84 | 7 | 4385_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 7.88e-06 | 195 | 84 | 7 | 2956_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.88e-06 | 195 | 84 | 7 | 4398_DN | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.15e-05 | 163 | 84 | 6 | 1498_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 166 | 84 | 6 | 5324_UP | |
| Drug | wortmannin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.68e-05 | 175 | 84 | 6 | 869_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 5.48e-05 | 180 | 84 | 6 | 3397_UP | |
| Drug | Capecitabine | 5.87e-05 | 57 | 84 | 4 | ctd:D000069287 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.01e-05 | 183 | 84 | 6 | 1074_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 6.19e-05 | 184 | 84 | 6 | 2691_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 6.57e-05 | 186 | 84 | 6 | 6996_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 6.77e-05 | 187 | 84 | 6 | 1043_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 7.39e-05 | 190 | 84 | 6 | 1612_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 4139_UP | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 5923_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 5265_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 4434_UP | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 3715_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 2856_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4120_UP | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 3145_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 5276_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4131_UP | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; HL60; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 3023_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 3756_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 7363_DN | |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | 9.28e-05 | 198 | 84 | 6 | 461_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 9.81e-05 | 200 | 84 | 6 | 2670_DN | |
| Disease | Antihypertensive use measurement | 9.16e-05 | 265 | 81 | 6 | EFO_0009927 | |
| Disease | myelofibrosis (implicated_via_orthology) | 1.11e-04 | 6 | 81 | 2 | DOID:4971 (implicated_via_orthology) | |
| Disease | Fuchs endothelial corneal dystrophy | 3.30e-04 | 10 | 81 | 2 | Orphanet_98974 | |
| Disease | apolipoprotein B measurement | 4.74e-04 | 663 | 81 | 8 | EFO_0004615 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 7.03e-04 | 63 | 81 | 3 | EFO_0022335 | |
| Disease | eosinophil count | NCOR2 CRTC3 ERBB3 FAM193A MDN1 GSE1 ATXN1 RPN1 INPP5D ERMP1 MYRF MYB | 7.26e-04 | 1488 | 81 | 12 | EFO_0004842 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.13e-04 | 264 | 81 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | filaggrin gene expression measurement | 8.71e-04 | 16 | 81 | 2 | EFO_0020899 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 1.23e-03 | 19 | 81 | 2 | OBA_2045140 | |
| Disease | neutrophil percentage of leukocytes | 1.45e-03 | 610 | 81 | 7 | EFO_0007990 | |
| Disease | total blood protein measurement | 1.49e-03 | 449 | 81 | 6 | EFO_0004536 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.77e-03 | 315 | 81 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.81e-03 | 23 | 81 | 2 | OBA_2045158 | |
| Disease | clinical and behavioural ideal cardiovascular health | 1.81e-03 | 23 | 81 | 2 | EFO_0007654 | |
| Disease | Coronary heart disease | 1.98e-03 | 24 | 81 | 2 | C0010068 | |
| Disease | Varicose veins | 1.99e-03 | 193 | 81 | 4 | HP_0002619 | |
| Disease | myeloproliferative disorder | 2.14e-03 | 25 | 81 | 2 | EFO_0004251 | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 2.14e-03 | 25 | 81 | 2 | EFO_0004465, EFO_0004466, EFO_0004469 | |
| Disease | Hyperplasia | 2.69e-03 | 28 | 81 | 2 | C0020507 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HVLQTAHPSPLSVYR | 271 | P13051 | |
| TRSPTVEYISAHPHI | 111 | Q9H9S4 | |
| PQYPHVVLAHETTTA | 211 | Q9Y2J4 | |
| AYHSQRHSLLTPVTP | 1131 | P21860 | |
| HSLTSALHYLVPVRP | 606 | Q8NHU2 | |
| LHELIPATTYHVQPA | 146 | P56559 | |
| VTGIPTHHPRVYNIH | 46 | O95415 | |
| ILVLHHPTTISPRYQ | 496 | O00178 | |
| HHVVPPSTVTEDYLR | 206 | Q14687 | |
| IHTSPSPGIQVRHVY | 101 | Q9H9E1 | |
| AAHVLSPTLPQYHPT | 1336 | Q8TDJ6 | |
| PGHRSYALSPHTVIQ | 421 | P54253 | |
| VYHPVQLSTPHAVGV | 326 | Q9UBM7 | |
| PYSPAVSHHIEAVVR | 21 | Q9Y2E6 | |
| LIHPTLYATPPFTHS | 471 | P78312 | |
| YTGISHITPHIPEIN | 716 | Q7Z2K6 | |
| LHSPPSEHYTIIFNT | 961 | Q16720 | |
| LGYLPPTVITILHTH | 1101 | Q2TAZ0 | |
| TDFHSVPPHYTELLT | 616 | Q96BY7 | |
| PDHTLTTELFHSNPY | 366 | Q6UXT9 | |
| HAEATIILHVESPPY | 3286 | P98160 | |
| QPSHAVHPLTPLITY | 146 | Q9UJU2 | |
| VHPLTPLITYSDEHF | 151 | Q9UJU2 | |
| LTPASSTHPNLHAYL | 326 | Q86TP1 | |
| PHSLSYPVQIARTHT | 21 | Q9Y618 | |
| LTLDTLTHPGYPHSS | 86 | Q8WY50 | |
| HTVPSLHAGLPSQEY | 171 | Q5HY92 | |
| VGISPDTHRVPYHIS | 606 | Q6Y2X3 | |
| QDPESYHTLPHEIVV | 2671 | Q9NU22 | |
| SHLISFCLYHTPVTP | 2971 | Q9NU22 | |
| SLLYDQPVTSPAHIH | 406 | Q9P2G4 | |
| TPIHPVYTSSRGDHL | 56 | O95202 | |
| PQIPHQTYSSILKHL | 706 | Q16659 | |
| VAICHPLHYPTILTN | 126 | Q8NGJ5 | |
| PELPITQHTHTLLSY | 271 | Q8NGJ8 | |
| PLLHTVHVLSAYASI | 136 | Q14999 | |
| YPQPVAVSHIAHTLS | 511 | Q99583 | |
| SSHVPYPVALHVNIV | 256 | P10242 | |
| HVQISYHSSHEPLPL | 91 | Q9ULW8 | |
| QHPSTPKRHTVLYIS | 131 | O94916 | |
| YQSLNLTHVPEHSAP | 281 | Q8IVV7 | |
| ASAIHNPIIYAITHP | 341 | Q9UHM6 | |
| SPHYVHSTRSVDISP | 681 | Q9P2Q2 | |
| TDHLHVTLSVVSYPP | 1731 | Q6WRI0 | |
| IQEHPVVLLPSHRSY | 151 | O15228 | |
| HYSTPLPASLDTTDH | 281 | Q6UUV7 | |
| PSHHYRILNSPVSLA | 576 | P57058 | |
| TAPEPHSLGILHASY | 31 | Q9H222 | |
| YSVQSTSPLIHIQHP | 361 | Q6ZMT9 | |
| TSPLIHIQHPSTYPF | 366 | Q6ZMT9 | |
| LPYQDTTIRTHPTLH | 21 | Q8N4S9 | |
| STLGTAPPTLALHYH | 91 | P12980 | |
| AVVASYLHEVQPHSP | 796 | Q5T7N3 | |
| LDSPTFHLTLHYPTE | 251 | P50895 | |
| SVGVHSAPSSLPYLH | 371 | Q13115 | |
| SIYTIRNHPHPLITV | 126 | Q5VW36 | |
| ASHPTHYDALILVTP | 291 | Q8WZA9 | |
| LLTPVLHHTTEGYPV | 391 | Q93100 | |
| HTIPPSLHIIVANLY | 276 | Q8NH56 | |
| HHPSPQEYRLLATTS | 21 | Q96NZ1 | |
| CPESHVPVSLSYHLS | 336 | Q7Z4G4 | |
| TQLIHVYLPLTSHIL | 401 | Q9Y5X2 | |
| LYGVTPSLEHPASLH | 206 | Q9GZV8 | |
| LTTTRAHYVPHLPIN | 371 | Q8IYX7 | |
| HGVPRTLSPHQYHSV | 491 | Q99593 | |
| VETVYTHVLHPYPTQ | 131 | P04843 | |
| THVLHPYPTQITQSE | 136 | P04843 | |
| ATETQLPIYTPLTHH | 826 | Q92835 | |
| SPTSQILHTDVVYLH | 556 | Q8N5C6 | |
| ILYRSHNASLHPTPE | 4381 | Q63HN8 | |
| YQEHVALHAPISTAP | 271 | Q5T7W0 | |
| IRTYHPPAQLTHTQF | 3311 | Q96T58 | |
| SHPLHNDPNLETVYT | 806 | P42285 | |
| VTAATYTPGALHPHL | 816 | Q6ZNA4 | |
| AYIPDHSHLVRSSVP | 356 | A0A1B0GUW6 | |
| HHLRSPAYSVSTIEP | 826 | O94991 | |
| HVHPLTPLITYSNEH | 196 | Q9NQB0 | |
| HVPVSSPLTQHQSYI | 1211 | O15014 | |
| VHAPVLPSTPTHYTL | 446 | Q86VD9 | |
| LPSTPTHYTLLFTHT | 451 | Q86VD9 | |
| IHPTEHSPTYLLIGT | 766 | Q9ULM0 | |
| LVHTDHAYQATPPVT | 301 | Q6ZNC4 | |
| HPRQDTYVSTPSEIH | 776 | O43379 | |
| SHSHLDAAPLPTVVY | 971 | Q8N398 | |
| HVSLSLSVHYPPQLL | 446 | Q96RL6 | |
| AYIHHPVAVPSESTI | 96 | P36508 | |
| LYSPGHSVLIIITHP | 271 | Q9NYW5 | |
| TETHVVRSPHPYQLP | 146 | O14773 | |
| HTLVSPVQHPYGLTL | 1246 | O75096 | |
| YHIPVSSGTPLHLSL | 1046 | Q9Y2G1 |